← Open Payments lookup

MICHAEL LARDON: Open Payments

NPI 1174630305 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,529 in 229 payments from 15 companies in 2025. Trend: 2023 $2,448 · 2024 $2,422 · 2025 $4,529

Food & beverage: $4,306Education: $223
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$736
Neurocrine BioSciences, Inc.23$679
Alkermes, Inc.30$543
Teva Pharmaceuticals USA, Inc.16$521
Otsuka America Pharmaceutical, Inc.31$396
E.R. Squibb & Sons, L.L.C.24$364
Vanda Pharmaceuticals Inc.23$243
Axsome Therapeutics, Inc.10$229
Bausch Health US, LLC13$203
ABBVIE INC.11$193

Products named: CAPLYTA, INGREZZA, ARISTADA, COBENFY, FANAPT, Auvelity, UZEDY, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.